Back to Journals » Cancer Management and Research » Volume 14

Original Research

The Efficacy and Safety of PD-1 Inhibitors Combined with Nab-Paclitaxel Plus Gemcitabine versus Nab-Paclitaxel Plus Gemcitabine in the First-Line Treatment of Advanced Pancreatic Cancer: A Retrospective Monocentric Study

       
Total article views   HTML views PDF downloads Totals
6,759 Dovepress* 5,939+ 396 6,335
PubMed Central* 820 190 1,010
Totals 6,759 586 7,345
*Since 9 February 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar